Generation of tumor neoantigens with photodynamic therapy: a new strategy for anticancer vaccines to fight head and neck cancer

Informazioni relative al progetto

PDT-NEO-immunother

ID dell’accordo di sovvenzione: 101108930

DOI

10.3030/101108930

Progetto chiuso

Data della firma CE 23 Marzo 2023

Data di avvio 1 Dicembre 2023

Data di completamento 30 Novembre 2025

Finanziato da

• Marie Skłodowska-Curie Actions (MSCA)

Costo totale

Nessun dato

Contributo UE

€ 175 920,00

Coordinato da

UNIVERSITEIT GENT
Belgium

CORDIS fornisce collegamenti ai risultati finali pubblici e alle pubblicazioni dei progetti ORIZZONTE.

I link ai risultati e alle pubblicazioni dei progetti del 7° PQ, così come i link ad alcuni tipi di risultati specifici come dataset e software, sono recuperati dinamicamente da .OpenAIRE .

Risultati finali

Data Management Plan (1)

Data Management Plan

The Data Management Plan describes the data management life cycle for all data sets that will be collected, processed or generated by the action. It is a document describing what data will be collected, processed or generated and following what methodology and standards, whether and how this data will be shared and/or made open, and how it will be curated and preserved.

Documents, reports (1)

Communication, Dissemination & Exploitation Plan

The plan describes the planned measures to maximize the impact of the project, including the dissemination and exploitation measures that are planned,and the target group(s) addressed. Regarding communication measures and public engagement strategy, the aim is to inform and reach out to society and show the activities performed, and the use and the benefits the project will have for citizens.

Pubblicazioni

Peer reviewed articles (3)

Immunogenicity of cell death and cancer immunotherapy with immune checkpoint inhibitors

Autori: Elena Catanzaro, Manuel Beltrán-Visiedo, Lorenzo Galluzzi, Dmitri V. Krysko
Pubblicato in: Cellular & Molecular Immunology, Numero 22, 2024, ISSN 2042-0226
Editore: Springer Science and Business Media LLC
DOI: 10.1038/S41423-024-01245-8

CX3CL1 release during immunogenic apoptosis is associated with enhanced anti-tumour immunity

Autori: Faye Naessens, Robin Demuynck, Olga Vershinina, Iuliia Efimova, Mariia Saviuk, Greet De Smet, Tatiana A. Mishchenko, Maria V. Vedunova, Olga Krysko, Elena Catanzaro, Dmitri V. Krysko
Pubblicato in: Frontiers in Immunology, Numero 15, 2024, ISSN 1664-3224
Editore: Frontiers Media SA
DOI: 10.3389/FIMMU.2024.1396349

Immunogenicity of ferroptosis in cancer: a matter of context?

Autori: Elena Catanzaro, Robin Demuynck, Faye Naessens, Lorenzo Galluzzi, Dmitri V. Krysko
Pubblicato in: Trends in Cancer, Numero 10, 2024, ISSN 2405-8033
Editore: Elsevier BV
DOI: 10.1016/J.TRECAN.2024.01.013